ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2022
Quantitative Radiomics Features in Diffuse Large B-Cell Lymphoma: Does Segmentation Method Matter?
Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Bibliometric and visual analysis of radiomics for evaluating lymph node status in oncology.Frontiers in medicine · 2024Pooled it
- Diagnostic Value ofTechnology in cancer research & treatmentPooled it
- A deep learning PET/CT biomarker for early progression (POD24) and survival stratification in follicular lymphoma: a multicenter study.European journal of nuclear medicine and molecular imaging · 2026Article
- Interpretable multimodal PET/CT-EHR fusion via mixture-of-experts for prognostic stratification in mantle cell lymphoma: a multicenter study.BMC medicine · 2026Article
- Segmentation method comparison for baseline [EJNMMI physics · 2026Article
- Prognostic Value of Massiveness Parameters Measured on Baseline FDG PET in Advanced-Stage Hodgkin Lymphoma.Cancer medicine · 2025Article
- A proof of concept study ofScientific reports · 2025Article
- Summary Report of the SNMMI AI Task Force Radiomics Challenge 2024.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025Article
- Association of [Diagnostics (Basel, Switzerland) · 2025Article
- Robust and interpretable deep learning system for prognostic stratification of extranodal natural killer/T-cell lymphoma.European journal of nuclear medicine and molecular imaging · 2025Article
- Prognostic Value of PretreatmentCancers · 2025Article
- Radiomics based onQuantitative imaging in medicine and surgery · 2025Article
- Review
- Mitigating the impact of image processing variations on tumour [Scientific reports · 2024Article
- Does consensus contour improve robustness and accuracy inEJNMMI physics · 2024Article
- Predicting T-Cell Lymphoma in Children FromJournal of imaging informatics in medicine · 2024Article
- Prognostic value of the combination of volume, massiveness and fragmentation parameters measured on baseline FDG pet in high-burden follicular lymphoma.Scientific reports · 2024Article
- Article
- PrognosticDiagnostics (Basel, Switzerland) · 2023Article
- A radiomics-clinical combined nomogram-based on non-enhanced CT for discriminating the risk stratification in GISTs.Journal of cancer research and clinical oncology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Radiomics features may predict outcome in diffuse large B-cell lymphoma (DLBCL). Currently, multiple segmentation methods are used to calculate metabolic tumor volume (MTV). We assessed the influence of segmentation method on the discriminative power of radiomics features in DLBCL at the patient level and for the largest lesion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.